- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,161GBP
- Report
- January 2025
- 210 Pages
Global
From €4406EUR$4,995USD£3,871GBP
- Report
- June 2025
- 89 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- November 2025
- 193 Pages
Global
From €4366EUR$4,950USD£3,836GBP
- Report
- November 2025
- 101 Pages
Global
From €3043EUR$3,450USD£2,673GBP
- Report
- May 2025
- 200 Pages
Asia Pacific
From €2196EUR$2,490USD£1,930GBP
- Report
- November 2025
- 97 Pages
Asia Pacific
From €3484EUR$3,950USD£3,061GBP
- Report
- November 2025
- 96 Pages
Europe
From €3484EUR$3,950USD£3,061GBP
- Report
- May 2023
- 143 Pages
Global
From €1985EUR$2,250USD£1,744GBP
- Report
- November 2021
- 295 Pages
Global
From €4851EUR$5,500USD£4,262GBP
- Report
- March 2025
- 200 Pages
India
From €2196EUR$2,490USD£1,930GBP
- Report
- February 2024
- 110 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- August 2022
- 109 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- October 2023
- 172 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- May 2024
- 134 Pages
Global
From €4873EUR$5,524USD£4,281GBP
€5733EUR$6,499USD£5,036GBP
- Report
- May 2024
- 129 Pages
Global
From €4873EUR$5,524USD£4,281GBP
€5733EUR$6,499USD£5,036GBP
- Report
- December 2024
- 150 Pages
Global
From €3396EUR$3,850USD£2,983GBP
€4278EUR$4,850USD£3,758GBP
- Report
- April 2023
- 147 Pages
Global
From €4365EUR$4,949USD£3,835GBP
- Report
- December 2023
- 180 Pages
Global
From €1103EUR$1,250USD£969GBP
€2205EUR$2,500USD£1,937GBP
- Report
- December 2023
- 100 Pages
Africa
From €1764EUR$2,000USD£1,550GBP

Amphotericin B is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. It is commonly used to treat systemic fungal infections, such as those affecting the lungs, heart, and central nervous system. It is also used to treat fungal infections of the skin, nails, and eyes. Amphotericin B is a polyene macrolide antibiotic, and is the most commonly used antifungal drug in the world. It is available in both intravenous and oral formulations, and is often used in combination with other antifungal drugs.
The Amphotericin B market is a subset of the larger Infectious Diseases Drugs market. It is a highly competitive market, with a number of companies offering Amphotericin B products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more